Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AMG-386/sorafenib combination shows promise in metastatic renal cell carcinoma

Feb. 28, 2011

CEQ-508 does not have adverse effects in nonhuman primates

Feb. 28, 2011

New NICE guidance recommends not using Avastin for metastatic breast cancer

Feb. 28, 2011

Everolimus is active in patients with transitional cell carcinoma of the urothelium

Feb. 28, 2011

Phase II pazopanib trial in urothelial cancer closed due to lack of activity

Feb. 28, 2011

Additional phase II data reported on paclitaxel nanoparticles in urothelial cancer

Feb. 28, 2011

Novartis claims new inhibitors of cyclin-dependent kinase 9

Feb. 25, 2011

Bayer and Onyx begin enrollment in phase III Nexavar trial in advanced breast cancer

Feb. 25, 2011

Enrollment complete in translational clinical study of Reolysin in metastatic colorectal cancer

Feb. 25, 2011

AR-42 displays potent antitumor effects in models of embryonal carcinoma

Feb. 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...